IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 241 - 260 of 1113 stories.
June 6, 2013
Johnson Matthey's (London) environmental technologies division posted a 7% increase in underlying operating profit for the fiscal year ended 31 March 2013, to £226 million on...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Mattheys-environmental-technologies-division-posts-higher-annual-profits-lower-sales_52657.html
June 4, 2013
Dr. Reddy's and Fujifilm call off JV for generic drugs in Japan, to explore opportunities in APIs Dr. Reddy’s Laboratories (Hyderabad, India) and Fujifilm (Tokyo) have decided to...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-4-June-2013_52542.html
June 3, 2013
Dr. Reddy’s Laboratories (Hyderabad, India) and Fujifilm (Tokyo) have decided to terminate their previously announced agreement for an exclusive partnership in the generic drugs...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Dr-Reddys-and-Fujifilm-call-off-JV-for-generic-drugs-in-Japan-to-explore-opportunities-in-APIs_52499.html
May 28, 2013
India outlines API export norms, to comply with new EU regulations India’s Ministry of Commerce & Industry (New Delhi) says that it is taking action in order to ensure that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-28-May_52323.html
May 24, 2013
India’s Ministry of Commerce & Industry (New Delhi) says that it is taking action in order to ensure that active pharmaceutical ingredients (APIs) exported from India into...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/India-outlines-API-export-norms-to-comply-with-new-EU-regulations_52287.html
May 22, 2013
FDA issued a warning letter earlier this month to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facility Boehringer Ingelheim (Ingelheim am...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-Boehringer-Ingelheim-API-plant_52231.html
May 22, 2013
Novo A/S (Hellerup, Denmark), parent of pharmaceutical firm Novo Nordisk (Bagsvaerd, Denmark), has acquired Xellia Pharmaceuticals (Oslo) from private equity firm 3i (London) for an...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Denmarks-Novo-acquires-Xellia-Pharmaceuticals-in-$700-million-deal_52226.html
May 21, 2013
Vertellus Specialties (Indianapolis) says that its facility at Antwerp has completed capital and other upgrades for the manufacture of niacin, or nicotinic acid, for pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Vertellus-upgrades-API-plant_52084.html
May 21, 2013
Actavis (Parsippany, NJ) and Warner Chilcott (Dublin) have entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a stock-for-stock transaction valued...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Actavis-to-acquire-Warner-Chilcott-in-deal-worth-up-to-$8-5-billion_52194.html
May 21, 2013
Cambrex completes Charles City facility expansion Cambrex (East Rutherford, NJ) says it has completed the previously announced expansion of the large-scale manufacturing facility at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-21-May-2013_52199.html
May 15, 2013
Cambrex (East Rutherford, NJ) says it has completed the previously announced expansion of the large-scale manufacturing facility at Charles City, IA. The major facility expansion was...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-completes-Charles-City-facility-expansion_52002.html
May 14, 2013
Ampac Fine Chemicals swings to profit Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of $3.8 million in its...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-14-May-2013_51978.html
May 14, 2013
Active pharmaceutical ingredients (APIs) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says that it has formed a strategic alliance with Coland Holdings (Shanghai) to develop a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-and-Coland-form-alliance-for-oncological-injectable-products-for-China_51973.html
May 14, 2013
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of $3.8 million in its fiscal second quarter, ended 31 March...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-swings-to-profit_51971.html
May 7, 2013
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel), recorded a 6.5% fall in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-7-May_51808.html
May 3, 2013
Cambrex (East Rutherford, NJ) reports a 58.6% increase in net profits for the first quarter, ended 31 March, compared with the year-ago period, to $11.16 million. First-quarter sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-rise-in-profits-and-sales_51752.html
May 3, 2013
Vertellus Specialties (Indianapolis) says that its facility at Antwerp has completed capital and other upgrades for the manufacture of niacin, or nicotinic acid, for pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Vertellus-upgrades-Belgium-facility-for-API-niacin-manufacture_51741.html
May 2, 2013
DSM's core net profit fell 13.4%, to €129 million ($170 million) during the first quarter of 2013, compared with the same period last year when it stood at €149 million, the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSMs-net-profit-falls-13-percent-in-the-first-quarter-as-performance-materials-sales-decline_51661.html
April 30, 2013
Lonza results in line with expectations Lonza, in its business update announcement for the first quarter of 2013, says that its business performance was solid and in line with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-30-April_51592.html
April 29, 2013
The active pharmaceutical ingredient (API) business of Covidien (Dublin) report an 11.4% rise in sales in the company’s second quarter, ended 29 March, compared with the year-ago...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Covidien-reports-rise-in-API-sales_51560.html
Pages: « Previous  4 5 6 7 8 9 10 11 12 [13] 14 15 16 17 18 19 20 21 22 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa